Assessment of AAIR Pacing Treatment for Heart Failure Patients With Chronotropic Incompetence
1 other identifier
observational
11
1 country
1
Brief Summary
The primary objective of this study is to assess the clinical efficacy of AAIR (Atrial-paced Atrial-sensed Inhibitory Rate-Modulated) pacing treatment for heart failure (HF) patients with chronotropic incompetence (CI) in terms of exercise tolerance and quality of life. Specifically, the study will assess the changes in cardiac function associated with changes of physical exercise intensity and heart rate in AAIR pacing mode compared with AAI pacing mode.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2016
CompletedStudy Start
First participant enrolled
October 9, 2016
CompletedFirst Posted
Study publicly available on registry
March 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 24, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 24, 2017
CompletedJanuary 11, 2018
January 1, 2018
1.1 years
September 8, 2016
January 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The treadmill walk duration change
The treadmill walk duration change from 3-6 months to 6-12 months post pacemaker implantation
Secondary Outcomes (1)
The 6 minutes hall walk distance change
3-6 months and 6-12 months post pacemaker implantation
Eligibility Criteria
In the study, total 30 heart failure patients with chronotropic incompetence who meet the inclusion and exclusion criteria would be enrolled from the ourtpatients in Fuwai Hospital.
You may qualify if:
- Patient is willing to give informed consent.
- Patient is between 18 and 70 years of age (including 18 and 70 years of age).
- Patients can perform treadmill exercise test for at least 8 minutes.
- Patient has been diagnosed with stable chronic HF according to HF guidance, including HFpEF (Heart Failure with preserved Ejection Fraction) and HFrEF (Heart Failure with reduced Ejection Fraction) patients.
- NYHA class I- III, with left ventricular ejection fraction less than 55% and more than 25%.
- Heart rate during treadmill test cannot reach 70% APMHR (Age Predicted Maximal Heart Rate) in (diagnostic criteria for CI, in accordance with class IA indications of pacing therapy for CI).
You may not qualify if:
- Patient with severe liver or kidney dysfunction.
- Patient has contraindications for pacing therapy.
- Patient has CI and is under appropriate clinical therapy.
- Patient has persistent or permanent atrial fibrillation (AF).
- Patient whose heart rate baseline at resting state is greater than 95 beats per minutes (BPM).
- Patient has contraindications for cardio-pulmonary exercise testing, including but not limited to unstable angina, decompensated heart failure, active pericarditis or myocarditis, hypertrophic cardiomyopathy, valvular heart disease and ECG ST-segment shift \> 2mm at resting state.
- Less than 6 months after angina and ST dynamic changes during last 3 months.
- Patient with class I (with PR interval more than 200ms), II or III atrioventricular block, or interventricular block.
- NYHA Class IV.
- Less than 45 days after myocardial infarction.
- Less than 3 months after acute heart failure.
- Patient has uncontrolled hypertension.
- Patient is unwilling to sign the patient informed consent.
- Patient is pregnant or has pregnancy intention in the study duration.
- Patient has a medical condition that would limit study participation.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fuwai Hospital
Beijing, Beijing Municipality, 100037, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shu Zhang, PhD
Chinese Academy of Medical Sciences, Fuwai Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2016
First Posted
March 7, 2017
Study Start
October 9, 2016
Primary Completion
November 24, 2017
Study Completion
November 24, 2017
Last Updated
January 11, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share